Cargando…
Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial
BACKGROUND: The effect of awake prone positioning on intubation rates is not established. The aim of this trial was to investigate if a protocol for awake prone positioning reduces the rate of endotracheal intubation compared with standard care among patients with moderate to severe hypoxemic respir...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200797/ https://www.ncbi.nlm.nih.gov/pubmed/34127046 http://dx.doi.org/10.1186/s13054-021-03602-9 |
_version_ | 1783707685169922048 |
---|---|
author | Rosén, Jacob von Oelreich, Erik Fors, Diddi Jonsson Fagerlund, Malin Taxbro, Knut Skorup, Paul Eby, Ludvig Campoccia Jalde, Francesca Johansson, Niclas Bergström, Gustav Frykholm, Peter |
author_facet | Rosén, Jacob von Oelreich, Erik Fors, Diddi Jonsson Fagerlund, Malin Taxbro, Knut Skorup, Paul Eby, Ludvig Campoccia Jalde, Francesca Johansson, Niclas Bergström, Gustav Frykholm, Peter |
author_sort | Rosén, Jacob |
collection | PubMed |
description | BACKGROUND: The effect of awake prone positioning on intubation rates is not established. The aim of this trial was to investigate if a protocol for awake prone positioning reduces the rate of endotracheal intubation compared with standard care among patients with moderate to severe hypoxemic respiratory failure due to COVID-19. METHODS: We conducted a multicenter randomized clinical trial. Adult patients with confirmed COVID-19, high-flow nasal oxygen or noninvasive ventilation for respiratory support and a PaO(2)/FiO(2) ratio ≤ 20 kPa were randomly assigned to a protocol targeting 16 h prone positioning per day or standard care. The primary endpoint was intubation within 30 days. Secondary endpoints included duration of awake prone positioning, 30-day mortality, ventilator-free days, hospital and intensive care unit length of stay, use of noninvasive ventilation, organ support and adverse events. The trial was terminated early due to futility. RESULTS: Of 141 patients assessed for eligibility, 75 were randomized of whom 39 were allocated to the control group and 36 to the prone group. Within 30 days after enrollment, 13 patients (33%) were intubated in the control group versus 12 patients (33%) in the prone group (HR 1.01 (95% CI 0.46–2.21), P = 0.99). Median prone duration was 3.4 h [IQR 1.8–8.4] in the control group compared with 9.0 h per day [IQR 4.4–10.6] in the prone group (P = 0.014). Nine patients (23%) in the control group had pressure sores compared with two patients (6%) in the prone group (difference − 18% (95% CI − 2 to − 33%); P = 0.032). There were no other differences in secondary outcomes between groups. CONCLUSIONS: The implemented protocol for awake prone positioning increased duration of prone positioning, but did not reduce the rate of intubation in patients with hypoxemic respiratory failure due to COVID-19 compared to standard care. TRIAL REGISTRATION: ISRCTN54917435. Registered 15 June 2020 (https://doi.org/10.1186/ISRCTN54917435). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03602-9. |
format | Online Article Text |
id | pubmed-8200797 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82007972021-06-15 Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial Rosén, Jacob von Oelreich, Erik Fors, Diddi Jonsson Fagerlund, Malin Taxbro, Knut Skorup, Paul Eby, Ludvig Campoccia Jalde, Francesca Johansson, Niclas Bergström, Gustav Frykholm, Peter Crit Care Research BACKGROUND: The effect of awake prone positioning on intubation rates is not established. The aim of this trial was to investigate if a protocol for awake prone positioning reduces the rate of endotracheal intubation compared with standard care among patients with moderate to severe hypoxemic respiratory failure due to COVID-19. METHODS: We conducted a multicenter randomized clinical trial. Adult patients with confirmed COVID-19, high-flow nasal oxygen or noninvasive ventilation for respiratory support and a PaO(2)/FiO(2) ratio ≤ 20 kPa were randomly assigned to a protocol targeting 16 h prone positioning per day or standard care. The primary endpoint was intubation within 30 days. Secondary endpoints included duration of awake prone positioning, 30-day mortality, ventilator-free days, hospital and intensive care unit length of stay, use of noninvasive ventilation, organ support and adverse events. The trial was terminated early due to futility. RESULTS: Of 141 patients assessed for eligibility, 75 were randomized of whom 39 were allocated to the control group and 36 to the prone group. Within 30 days after enrollment, 13 patients (33%) were intubated in the control group versus 12 patients (33%) in the prone group (HR 1.01 (95% CI 0.46–2.21), P = 0.99). Median prone duration was 3.4 h [IQR 1.8–8.4] in the control group compared with 9.0 h per day [IQR 4.4–10.6] in the prone group (P = 0.014). Nine patients (23%) in the control group had pressure sores compared with two patients (6%) in the prone group (difference − 18% (95% CI − 2 to − 33%); P = 0.032). There were no other differences in secondary outcomes between groups. CONCLUSIONS: The implemented protocol for awake prone positioning increased duration of prone positioning, but did not reduce the rate of intubation in patients with hypoxemic respiratory failure due to COVID-19 compared to standard care. TRIAL REGISTRATION: ISRCTN54917435. Registered 15 June 2020 (https://doi.org/10.1186/ISRCTN54917435). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13054-021-03602-9. BioMed Central 2021-06-14 /pmc/articles/PMC8200797/ /pubmed/34127046 http://dx.doi.org/10.1186/s13054-021-03602-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Rosén, Jacob von Oelreich, Erik Fors, Diddi Jonsson Fagerlund, Malin Taxbro, Knut Skorup, Paul Eby, Ludvig Campoccia Jalde, Francesca Johansson, Niclas Bergström, Gustav Frykholm, Peter Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial |
title | Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial |
title_full | Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial |
title_fullStr | Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial |
title_full_unstemmed | Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial |
title_short | Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial |
title_sort | awake prone positioning in patients with hypoxemic respiratory failure due to covid-19: the proflo multicenter randomized clinical trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200797/ https://www.ncbi.nlm.nih.gov/pubmed/34127046 http://dx.doi.org/10.1186/s13054-021-03602-9 |
work_keys_str_mv | AT rosenjacob awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial AT vonoelreicherik awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial AT forsdiddi awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial AT jonssonfagerlundmalin awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial AT taxbroknut awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial AT skoruppaul awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial AT ebyludvig awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial AT campocciajaldefrancesca awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial AT johanssonniclas awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial AT bergstromgustav awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial AT frykholmpeter awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial AT awakepronepositioninginpatientswithhypoxemicrespiratoryfailureduetocovid19theproflomulticenterrandomizedclinicaltrial |